Transform your business with AI startup: opportunities and innovations that will change the game
Piter Bowman
Alluvi Labs develops and evaluates premium peptides and supplements.
All products are produced exclusively for controlled research and development purposes, guided by science. Not for human or veterinary consumption.
Retatrutide – Pre-Filled Pen Evaluation
Part of Alluvi Labs’ ongoing research program into advanced GLP-1 multi-agonist compounds.
This formulation is supplied in controlled batches for laboratory analysis of stability, compound behaviour, and injector system performance.
Not for human or veterinary consumption.
Power-Up in a Gummy
A delicious way to fuel your body with protein and creatine – Alluvi Gummy Bears are a quick, convenient solution to stay on top of daily nutrients. No scoops. No shakes. Just results.
Recovery Meets Routine
Daily gummy supplements crafted for sleep, stress support, and muscle recovery – for rest and protein for strength, all in a clean, delicious form.
Alluvi pens are supplied ready-to-use – no mixing, no guesswork.
Developed for controlled research applications, each unit features fixed pre-measured volumes to support consistency and reliability during laboratory evaluation.
Not for human or veterinary consumption.
Proven Data. Backed by Research.
Published studies have investigated GLP-1 multi-agonist compounds under controlled conditions.
Alluvi supplies Retatrutide pens exclusively for laboratory research and development.
Not for human or veterinary consumption.
All figures are derived from third party published studies and are shown only for academic context. All Alluvi products are supplied strictly for laboratory research purposes.
22.5%
Reference value drawn from published research on GLP-1 multi-agonist compounds.
Provided strictly as scientific context.
6oo
Participants consumed fewer calories per day without being instructed to diet – driven by decreased appetite and satiety signaling.
Provided strictly as scientific context.
28%
Reported value in published research relating to GLP-1 multi-agonist compounds.
Provided strictly as a scientific reference point.
18.3 KG
Example data point referenced in peer-reviewed studies for GLP-1 multi-agonists.
Alluvi does not promote or imply medical use of its products.
